The Journal of Immunology, Vol 131, Issue 2 762-767, Copyright © 1983 by American Association of Immunologists

ARTICLES

A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states

RI Fox, M Hueniken, S Fong, S Behar, I Royston, SK Singhal and L Thompson

Monoclonal antibody T305, prepared by immunizing mice with the T-ALL derived cell line RPMI-8402, immunoprecipitates a single chain glycoprotein with m.w. 160,000 daltons (under reducing conditions) or 180,000 daltons (under nonreducing conditions). In immunofluorescence assays, antibody T305 reacted with a subpopulation of T cells in normal blood (22 +/- 6%), thymus (28 +/- 11%), and lymph node (24 +/- 6%). Increased frequency of T cells reactive with antibody T305 was found in peripheral blood of patients with infectious mononucleosis (greater than 80%), graft-vs-host disease after bone marrow transplantation (65 +/- 11%), acquired immunodeficiency syndrome (53 +/- 12%). The T cells in synovial fluid of patients with rheumatoid arthritis had increased frequency of antibody T305 reactive cells (59 +/- 8%) as compared to their peripheral blood (18 +/- 7%). Two color immunofluorescent studies demonstrated that the T305+ T cells predominantly co-stained with antibody Leu 2a (suppressor/cytotoxic subset) in both normals and disease state blood. After cell sorting to obtain T305+ and T305- subpopulations, we demonstrated that a) natural killer and antibody- dependent cellular cytotoxicity activity in normal blood was in the T305+ but not T305- T cells; b) cytotoxic T cells induced by mixed lymphocyte reaction were predominantly T305+; c) T305- T cells could be induced in vitro to express T305 antigen by mitogens or allogeneic B cells; d) the DNA content of T305+ and T305- T cells in normal blood was similar (greater 95% of cells with G0/G1 level); e) after mitogen stimulation, T305 antigen induction on previously T305- cells occurs before S-phase; and f) significantly more [3H]-thymidine after mitogen stimulation was incorporated by originally T305- cells than by originally T305+ cells (p less than 0.001). The T305 antigen was not restricted to T cells because it was also found on myeloid precursors in bone marrow but was not present on polymorphonuclear leukocytes, red blood cells, platelets, muscle, liver, skin, kidney, lung, or brain. Antibody T305 was found on 24/25 cases of acute leukemia (6 T-ALL, 10/11 cALL, 7 AML, and 1 AMOL) but not on 18 cases of chronic leukemia (B-CLL, T-CLL, null CLL, CML). The importance of the T305 antigen is that it is present on a high number of T cells in certain autoimmune diseases and on virtually all acute leukemia cells. Its distribution on immature and in vitro activated cells suggests that it may represent a receptor for signals related to cellular replication or differentiation.

This article has been cited by other articles:

				J. D. Hernandez, J. T. Nguyen, J. He, W. Wang, B. Ardman, J. M. Green, M. Fukuda, and L. G. Baum Galectin-1 Binds Different CD43 Glycoforms to Cluster CD43 and Regulate T Cell Death J. Immunol., October 15, 2006; 177(8): 5328 - 5336. [Abstract] [Full Text] [PDF]

				J. T. Nguyen, D. P. Evans, M. Galvan, K. E. Pace, D. Leitenberg, T. N. Bui, and L. G. Baum CD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O-Glycans J. Immunol., November 15, 2001; 167(10): 5697 - 5707. [Abstract] [Full Text] [PDF]

				T. Schwientek, J.-C. Yeh, S. B. Levery, B. Keck, G. Merkx, A. G. van Kessel, M. Fukuda, and H. Clausen Control of O-Glycan Branch Formation. MOLECULAR CLONING AND CHARACTERIZATION OF A NOVEL THYMUS-ASSOCIATED CORE 2 beta 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE J. Biol. Chem., April 6, 2000; 275(15): 11106 - 11113. [Abstract] [Full Text] [PDF]

				M. Fabbi, J. Geginat, M. Tiso, D. Ramarli, D. Parent, A. Bargellesi, and E. Remold-O'Donnell 8B4/20, A Private CD43 Epitope on Developing Human Thymocytes, Is Involved in Thymocyte Maturation J. Immunol., December 1, 1999; 163(11): 5964 - 5970. [Abstract] [Full Text] [PDF]

				R. Mukasa, T. Homma, T. Ohtsuki, O. Hosono, A. Souta, T. Kitamura, M. Fukuda, S. Watanabe, and C. Morimoto Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells Int. Immunol., February 1, 1999; 11(2): 259 - 268. [Abstract] [Full Text] [PDF]

				T. J. Brown, W. W. Shuford, W.-C. Wang, S. G. Nadler, T. S. Bailey, H. Marquardt, and R. S. Mittler Characterization of a CD43/Leukosialin-mediated Pathway for Inducing Apoptosis in Human T-Lymphoblastoid Cells J. Biol. Chem., November 1, 1996; 271(44): 27686 - 27695. [Abstract] [Full Text] [PDF]

				L. G. Baum, K. Derbin, N. L. Perillo, T. Wu, M. Pang, and C. Uittenbogaart Characterization of Terminal Sialic Acid Linkages on Human Thymocytes J. Biol. Chem., May 3, 1996; 271(18): 10793 - 10799. [Abstract] [Full Text] [PDF]

				G. Crabtree Contingent genetic regulatory events in T lymphocyte activation Science, January 20, 1989; 243(4889): 355 - 361. [Abstract] [PDF]

				M. Galvan, S. Tsuboi, M. Fukuda, and L. G. Baum Expression of a Specific Glycosyltransferase Enzyme Regulates T Cell Death Mediated by Galectin-1 J. Biol. Chem., May 26, 2000; 275(22): 16730 - 16737. [Abstract] [Full Text] [PDF]